Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II ofatumumab in MALT lymphoma
2012-005223-32Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Aug 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of ofatumumab in extranodal marginal zone B-cell lymphoma (EMZL), sponsored by Medical University of Vienna. Started Aug 2013; status: completed.
02
Drugs
ofatumumab
03
Conditions
extranodal marginal zone B-cell lymphoma (EMZL)
Beyond the preview
Go deeper on 2012-005223-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005223-32.